002412 汉森制药
已收盘 11-20 15:00:00
资讯
新帖
简况
股市必读:汉森制药(002412)11月16日董秘有最新回复
证券之星 · 11-17
股市必读:汉森制药(002412)11月16日董秘有最新回复
汉森制药:截至2026年10月30日,公司含信用账户合并股东名册的股东总数为
证券之星 · 11-16
汉森制药:截至2026年10月30日,公司含信用账户合并股东名册的股东总数为
股市必读:汉森制药新发布《关于获得药物临床试验批准通知书的公告》
证券之星 · 11-11
股市必读:汉森制药新发布《关于获得药物临床试验批准通知书的公告》
汉森制药:截至2026年10月30日股东总数为41,955人
证券之星 · 11-10
汉森制药:截至2026年10月30日股东总数为41,955人
股市必读:汉森制药(002412)11月2日董秘有最新回复
证券之星 · 11-03
股市必读:汉森制药(002412)11月2日董秘有最新回复
汉森制药:截至2026年10月30日股东总数为41,955人
证券之星 · 11-02
汉森制药:截至2026年10月30日股东总数为41,955人
汉森制药(002412)9月30日股东户数5.22万户,较上期减少42.89%
证券之星 · 10-27
汉森制药(002412)9月30日股东户数5.22万户,较上期减少42.89%
股市必读:汉森制药新发布《2026年三季度报告》
证券之星 · 10-27
股市必读:汉森制药新发布《2026年三季度报告》
图解汉森制药三季报:第三季度单季净利润同比增长255.60%
证券之星 · 10-27
图解汉森制药三季报:第三季度单季净利润同比增长255.60%
股市必读:汉森制药(002412)10月22日收盘跌6.15%,主力净流出853.49万元
证券之星 · 10-23
股市必读:汉森制药(002412)10月22日收盘跌6.15%,主力净流出853.49万元
汉森制药:截至2026年9月30日的公司股东人数
证券之星 · 10-19
汉森制药:截至2026年9月30日的公司股东人数
汉森制药(002412)10月16日主力资金净卖出21.75万元
证券之星 · 10-19
汉森制药(002412)10月16日主力资金净卖出21.75万元
汉森制药(002412)10月12日主力资金净卖出975.83万元
证券之星 · 10-13
汉森制药(002412)10月12日主力资金净卖出975.83万元
汉森制药(002412)9月30日主力资金净买入744.58万元
证券之星 · 10-08
汉森制药(002412)9月30日主力资金净买入744.58万元
9月21日汉森制药涨6.42%,中欧量化先锋混合A基金重仓该股
证券之星 · 09-21
9月21日汉森制药涨6.42%,中欧量化先锋混合A基金重仓该股
汉森制药:截至2026年8月31日股东总数为91,475人
证券之星 · 09-17
汉森制药:截至2026年8月31日股东总数为91,475人
汉森制药(002412)8月31日股东户数9.15万户,较上期增加169.52%
证券之星 · 09-09
汉森制药(002412)8月31日股东户数9.15万户,较上期增加169.52%
汉森制药:截至2026年8月31日股东总数为91,475人
证券之星 · 09-09
汉森制药:截至2026年8月31日股东总数为91,475人
汉森制药:9月2日召开业绩说明会,投资者参与
证券之星 · 09-07
汉森制药:9月2日召开业绩说明会,投资者参与
9月2日汉森制药(002412)龙虎榜数据:机构净卖出4429.11万元(3日)
证券之星 · 09-02
9月2日汉森制药(002412)龙虎榜数据:机构净卖出4429.11万元(3日)
公司概况
公司名称:
湖南汉森制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-05-25
主营业务:
湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是消化系统用药、心脑血管用药、补肾缩尿用药、伤科用药、诊断用药。
发行价格:
35.80
{"stockData":{"symbol":"002412","market":"SZ","secType":"STK","nameCN":"汉森制药","latestPrice":6.6,"timestamp":1795158189000,"preClose":6.92,"halted":0,"volume":11364043,"delay":0,"changeRate":-0.0462,"floatShares":498000000,"shares":503000000,"eps":0.5404,"marketStatus":"已收盘","change":-0.32,"latestTime":"11-20 15:00:00","open":6.75,"high":6.85,"low":6.6,"amount":76285200,"amplitude":0.0361,"askPrice":6.61,"askSize":318,"bidPrice":6.6,"bidSize":591,"shortable":0,"etf":0,"ttmEps":0.5404,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.92,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":7.61,"lowLimit":6.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":503200000,"isCdr":false,"pbRate":1.46,"roa":"--","peRate":12.213175,"roe":"6.0%","epsLYR":0.3937,"committee":-0.20221,"marketValue":3321000000,"turnoverRate":0.0228,"status":1,"floatMarketCap":3286000000},"requestUrl":"/m/hq/s/002412/wiki","defaultTab":"wiki","newsList":[{"id":"2684641108","title":"股市必读:汉森制药(002412)11月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684641108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684641108?lang=zh_cn&edition=full","pubTime":"2026-11-17 01:52","pubTimestamp":1794851541,"startTime":"0","endTime":"0","summary":"截至2026年11月16日收盘,汉森制药报收于7.38元,下跌2.89%,换手率2.36%,成交量11.74万手,成交额8750.73万元。董秘最新回复投资者: 请问公司截止2026年11月10日的股东户数是多少?谢谢董秘: 尊敬的投资者您好,公司可在互动易平台回复非定期报告时点的月末股东人数,截至2026年10月30日,公司含信用账户合并股东名册的股东总数为:41,955人。当日关注点交易信息汇总:11月16日主力资金净流出708.08万元,占总成交额8.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700001138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","002412","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683694407","title":"汉森制药:截至2026年10月30日,公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2683694407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683694407?lang=zh_cn&edition=full","pubTime":"2026-11-16 17:00","pubTimestamp":1794819641,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)11月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止2026年11月10日的股东户数是多少?谢谢汉森制药回复:尊敬的投资者您好,公司可在互动易平台回复非定期报告时点的月末股东人数,截至2026年10月30日,公司含信用账户合并股东名册的股东总数为:41,955人。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600022853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0239","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682016317","title":"股市必读:汉森制药新发布《关于获得药物临床试验批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682016317","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682016317?lang=zh_cn&edition=full","pubTime":"2026-11-11 02:12","pubTimestamp":1794334333,"startTime":"0","endTime":"0","summary":"公司公告汇总关于获得药物临床试验批准通知书的公告湖南汉森制药股份有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,同意四磨汤口服液开展用于非糜烂性反流病的临床试验。该药品为中药2.3类,已纳入国家基本药物目录和国家医保目录。本次为增加功能主治的临床试验申请获批,需经国家药监部门批准注册后方可载入说明书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100005441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0239","BK0039","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682355811","title":"汉森制药:截至2026年10月30日股东总数为41,955人","url":"https://stock-news.laohu8.com/highlight/detail?id=2682355811","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682355811?lang=zh_cn&edition=full","pubTime":"2026-11-10 08:57","pubTimestamp":1794272232,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:最近股东人数及公布日期汉森制药回复:尊敬的投资者您好,截至2026年10月30日,公司含信用账户合并股东名册的股东总数为:41,955人。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680624397","title":"股市必读:汉森制药(002412)11月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680624397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680624397?lang=zh_cn&edition=full","pubTime":"2026-11-03 02:23","pubTimestamp":1793643808,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,汉森制药报收于7.75元,上涨3.61%,换手率4.75%,成交量23.65万手,成交额1.8亿元。董秘最新回复投资者: 请问公司最新一期的股东户数是多少?谢谢董秘: 尊敬的投资者您好,截至2026年10月30日,公司含信用账户合并股东名册的股东总数为:41,955人。当日关注点交易信息汇总:11月2日主力资金净流入307.51万元,占总成交额1.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300004189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002412","BK0039","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680374887","title":"汉森制药:截至2026年10月30日股东总数为41,955人","url":"https://stock-news.laohu8.com/highlight/detail?id=2680374887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680374887?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:15","pubTimestamp":1793610907,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)11月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最新一期的股东户数是多少?谢谢汉森制药回复:尊敬的投资者您好,截至2026年10月30日,公司含信用账户合并股东名册的股东总数为:41,955人。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200024826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175884","title":"汉森制药(002412)9月30日股东户数5.22万户,较上期减少42.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175884?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:43","pubTimestamp":1793097805,"startTime":"0","endTime":"0","summary":"证券之星消息,近日汉森制药披露,截至2026年9月30日公司股东户数为5.22万户,较8月31日减少3.92万户,减幅为42.89%。在中药行业个股中,汉森制药股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.24万户。从股价来看,2026年8月31日至2026年9月30日,汉森制药区间跌幅为23.27%,在此期间股东户数减少3.92万户,减幅为42.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678116332","title":"股市必读:汉森制药新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678116332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678116332?lang=zh_cn&edition=full","pubTime":"2026-10-27 03:52","pubTimestamp":1793044330,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年三季度报告湖南汉森制药股份有限公司2026年第三季度营业收入为232,987,721.42元,同比增长0.45%;归属于上市公司股东的净利润为49,737,455.28元,同比增长255.60%。第七届董事会第五次会议决议的公告湖南汉森制药股份有限公司于2026年10月23日召开第七届董事会第五次会议,审议通过《2026年第三季度报告》和《关于增加使用自有资金进行现金管理额度的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700005963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678211347","title":"图解汉森制药三季报:第三季度单季净利润同比增长255.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678211347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678211347?lang=zh_cn&edition=full","pubTime":"2026-10-27 02:37","pubTimestamp":1793039854,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药2026年三季报显示,前三季度公司主营收入7.09亿元,同比下降4.27%;归母净利润1.56亿元,同比上升89.43%;扣非净利润1.49亿元,同比上升93.35%;其中2026年第三季度,公司单季度主营收入2.33亿元,同比上升0.45%;单季度归母净利润4973.75万元,同比上升255.6%;单季度扣非净利润4794.01万元,同比上升287.6%;负债率4.1%,投资收益2411.0万元,财务费用-25.54万元,毛利率78.16%。财报数据概要请见下图:本文数据来源于汉森制药2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677993341","title":"股市必读:汉森制药(002412)10月22日收盘跌6.15%,主力净流出853.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677993341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677993341?lang=zh_cn&edition=full","pubTime":"2026-10-23 02:23","pubTimestamp":1792693389,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,汉森制药报收于7.63元,下跌6.15%,换手率4.39%,成交量21.87万手,成交额1.7亿元。当日关注点交易信息汇总:汉森制药10月22日收盘价7.63元,跌6.15%,当日成交1.7亿元,主力资金净流出853.49万元。资金流向10月22日主力资金净流出853.49万元,占总成交额5.03%;游资资金净流出53.91万元,占总成交额0.32%;散户资金净流入907.4万元,占总成交额5.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300002338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509361","title":"汉森制药:截至2026年9月30日的公司股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509361?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:21","pubTimestamp":1792398069,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)10月19日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年10月10日公司的股东人数是多少?谢谢汉森制药回复:尊敬的投资者您好,公司可在互动易平台回复非定期报告时点的月末股东人数,截至2026年9月30日的公司股东人数,公司将在2026年第三季度报告中披露,后续可关注公司在指定信息披露媒体及巨潮资讯网(www.cninfo.com.cn)披露的相关公告。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900019482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676157184","title":"汉森制药(002412)10月16日主力资金净卖出21.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676157184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676157184?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:18","pubTimestamp":1792372711,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月16日收盘,汉森制药报收于8.25元,下跌2.48%,换手率7.59%,成交量37.79万手,成交额3.24亿元。近5日资金流向一览见下表:汉森制药融资融券信息显示,融资方面,当日融资买入2417.74万元,融资偿还2924.59万元,融资净偿还506.85万元。汉森制药主营业务:公司是一家集研发、生产、销售为一体的医药制造企业,生产中药制剂为主,化学药为辅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","002412","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675389286","title":"汉森制药(002412)10月12日主力资金净卖出975.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675389286","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675389286?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:16","pubTimestamp":1791854182,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月12日收盘,汉森制药报收于8.65元,下跌5.77%,换手率5.93%,成交量29.54万手,成交额2.61亿元。近5日资金流向一览见下表:汉森制药融资融券信息显示,融资方面,当日融资买入2120.14万元,融资偿还2952.42万元,融资净偿还832.29万元。汉森制药主营业务:公司是一家集研发、生产、销售为一体的医药制造企业,生产中药制剂为主,化学药为辅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300008485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049719","title":"汉森制药(002412)9月30日主力资金净买入744.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049719","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049719?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:07","pubTimestamp":1791421655,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,汉森制药报收于9.07元,上涨2.83%,换手率11.92%,成交量59.34万手,成交额5.44亿元。近5日资金流向一览见下表:汉森制药融资融券信息显示,融资方面,当日融资买入4425.87万元,融资偿还4295.76万元,融资净买入130.11万元。汉森制药主营业务:公司是一家集研发、生产、销售为一体的医药制造企业,生产中药制剂为主,化学药为辅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","BK0239","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159297","title":"9月21日汉森制药涨6.42%,中欧量化先锋混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159297?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980293,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日汉森制药涨6.42%,收盘报9.62元,换手率16.99%,成交量84.59万手,成交额8.02亿元。重仓汉森制药的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为中欧基金的中欧量化先锋混合A。中欧量化先锋混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668414957","title":"汉森制药:截至2026年8月31日股东总数为91,475人","url":"https://stock-news.laohu8.com/highlight/detail?id=2668414957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668414957?lang=zh_cn&edition=full","pubTime":"2026-09-17 16:15","pubTimestamp":1789632910,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司9月10日股东人数是多少?谢谢汉森制药回复:尊敬的投资者您好,公司可在互动易平台回复非定期报告时点的月末股东人数,截至2026年8月31日,公司含信用账户合并股东名册的股东总数为:91,475人。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700023687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589088","title":"汉森制药(002412)8月31日股东户数9.15万户,较上期增加169.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666589088?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:27","pubTimestamp":1788946050,"startTime":"0","endTime":"0","summary":"证券之星消息,近日汉森制药披露,截至2026年8月31日公司股东户数为9.15万户,较7月31日增加5.75万户,增幅为169.52%。在中药行业个股中,汉森制药股东户数高于行业平均水平,截至8月31日,中药行业平均股东户数为5.26万户。从股价来看,2026年7月31日至2026年8月31日,汉森制药区间涨幅为75.11%,在此期间股东户数增加5.75万户,增幅为169.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","BK0239","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666732301","title":"汉森制药:截至2026年8月31日股东总数为91,475人","url":"https://stock-news.laohu8.com/highlight/detail?id=2666732301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666732301?lang=zh_cn&edition=full","pubTime":"2026-09-09 11:36","pubTimestamp":1788925013,"startTime":"0","endTime":"0","summary":"证券之星消息,汉森制药(002412)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,目前为止,截止八月底,公司股东人数是多少?汉森制药回复:尊敬的投资者您好,截至2026年8月31日,公司含信用账户合并股东名册的股东总数为:91,475人。感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900015095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319577","title":"汉森制药:9月2日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319577","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319577?lang=zh_cn&edition=full","pubTime":"2026-09-07 16:52","pubTimestamp":1788771132,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月2日汉森制药发布公告称公司于2026年9月2日召开业绩说明会。汉森制药2026年中报显示,上半年度公司主营收入4.76亿元,同比下降6.42%;归母净利润1.07亿元,同比上升55.52%;扣非净利润1.01亿元,同比上升56.26%;其中2026年第二季度,公司单季度主营收入2.13亿元,同比下降11.11%;单季度归母净利润6818.55万元,同比上升19.04%;单季度扣非净利润6512.1万元,同比上升17.01%;负债率4.18%,投资收益2232.7万元,财务费用8.88万元,毛利率78.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700021487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890258","title":"9月2日汉森制药(002412)龙虎榜数据:机构净卖出4429.11万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890258?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:32","pubTimestamp":1788341554,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年9月2日公布的交易公开信息显示,汉森制药因连续三个交易日内,跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年9月2日收盘,汉森制药报收于10.26元,下跌8.06%,换手率21.58%,成交量107.44万手,成交额11.16亿元。从龙虎榜公布的三日买卖数据来看,机构合计净卖出4429.11万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200031265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795299111509,"stockEarnings":[{"period":"1week","weight":-0.1316},{"period":"1month","weight":-0.1882},{"period":"3month","weight":-0.3523},{"period":"6month","weight":-0.0021},{"period":"1year","weight":0.0199},{"period":"ytd","weight":0.0788}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南汉森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41955人(较上一季度减少19.69%)","perCapita":"11866股","listingDate":"2010-05-25","address":"湖南省益阳市赫山区银城大道2688号","registeredCapital":"50320万元","survey":" 湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是消化系统用药、心脑血管用药、补肾缩尿用药、伤科用药、诊断用药。","listedPrice":35.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉森制药,002412,汉森制药股票,汉森制药股票老虎,汉森制药股票老虎国际,汉森制药行情,汉森制药股票行情,汉森制药股价,汉森制药股市,汉森制药股票价格,汉森制药股票交易,汉森制药股票购买,汉森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}